Crossmark

Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma

Crossref DOI link: https://doi.org/10.1038/s41375-022-01588-z

Published Online: 2022-05-05

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Adamia, Sophia https://orcid.org/0000-0001-5704-6040
Bhatt, Shruti

Wen, Kenneth

Chyra, Zuzana

Fell, Geoffrey G.

Tai, Yu-Tzu https://orcid.org/0000-0001-6199-3569
Pioso, Marissa S.

Abiatari, Ivane

Letai, Anthony https://orcid.org/0000-0002-1993-9013
Dorfman, David M.

Hideshima, Teru

Anderson, Kenneth C. https://orcid.org/0000-0002-6418-0886
License Information

Text and Data Mining valid from 2022-05-05

Version of Record valid from 2022-05-05
More Information

Article History

First Online: 5 May 2022